NCT00015847 2025-08-22Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaOHSU Knight Cancer InstitutePhase 2 Terminated25 enrolled 8 charts
NCT03333486 2025-07-04Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood CancerRoswell Park Cancer InstitutePhase 2 Terminated31 enrolled 18 charts